1Q22 Investor Update
ONE OF THE MOST STRATEGICALLY POSITIONED MSOS
Addressable market is >53% of the U.S. population with significant upside potential
Adult Use Anticipated
Adult Use & Medical
123
Columbia Care U.S. Footprint
Medical Only
Pursuit Activity
Conversion to Medical and Adult-Use Offers Significant Upside
Columbia Care has experienced 3x-4x top-line revenue growth in states that
have already converted from medical-only to medical and adult-use
2)
$36B+
Projected 2026 TAM in
Licensed US
States (2)
Adult-use sales launched in New Jersey in April 2022 and are expected in
New York in 2023 and Virginia in 2024
Columbia Care's expansive footprint is well positioned for the anticipated
conversion of additional markets
State
California
Florida
Colorado
Illinois
Massachusetts
Pennsylvania
Arizona
New Jersey
Maryland
Ohio
Missouri (3)
New York
Utah
Virginia
Washington DC
Delaware
US Census Bureau, Company estimates, Gallup poll, as of Nov 2020
Estimated Sales figures from BDSA Market Forecast as of March 2022, broker research, company estimates
3) Consultative services provided pursuant to terms of a management services arrangement
West Virginia
TOTAL
*Adult-use sales pending
Columbia Care Addressable Market (2)
Est 2022 Sales (US$M) Est 2026 Sales (US$M)
$
$
Population (M)
39.6
21.3
5.7
12.7
6.9
12.8
7.2
8.9
6
$
$
$
GA
A: A
11.7
6.1
19.5
3.2
8.5
0.7
1
1.8
173.6 $
CA CA
$
$
:
$
SA
$
4,188.2
2,318.8
2,124.6
2,048.4
1,845.3
1,607.7
1,485.9
792.2
609.6
507.5
361.4
189.2
132.3
78.5
64.2
42.3
18.1
18,414.2
$
$
$
$
$
$
$
6,547.5
3,356.9
2,395.0
2,545.2
2,343.8
2,197.8
1,838.6
3,000.0(2)
1,275.1
1,374.8
934.9
5,000.0(2)
311.7
3,000.0(2)
237.0
132.9
51.8
36,543.0
Status
Both
Medical
Both
Both
Both
Medical
Both
Both
Medical
Medical
Medical
Both*
Medical
Both*
Medical
Medical
Medical
Licenses
Unlimited
Limited
Unlimited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
6
Columbia Care™View entire presentation